Search


You have searched for "Cholesterol"

Showing 1-10 of 111

Sort by: Newest | Oldest | Relevance


Business 18 Nov 2010 | 12:00 AM Premium

New drug claims steep drop in bad cholesterol; boosts good cholestrol

CHICAGO: An experimental drug boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attacks and strokes.

Business 31 Mar 2014 | 6:47 AM Premium

Alternative treatment for cholesterol shows promise

WASHINGTON: An experimental treatment has shown promise in lowering bad cholesterol, offering hope for people at risk of heart disease but who cannot tolerate drugs known as statins, researchers said Sunday.

Business 25 Apr 2013 | 12:00 AM Premium

Is there another factor other than cholesterol and triglycerides causing heart attacks?

NEW YORK: Thousands of heart attack victims every year have none of the notorious risk factors before their crisis - not high cholesterol, not unhealthy triglycerides

Business 03 Dec 2006 | 12:00 AM Premium

Pfizer cuts off development on cholesterol drug

NEW YORK (AP): Pfizer Inc. said it has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it.

Business 16 Nov 2009 | 12:00 AM Premium

Study raises new questions about Merck pill Zetia

ORLANDO, Florida (AP): A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of people to lower cholesterol, despite questions raised last year about how well they work.

Business 23 Dec 2003 | 12:00 AM Premium

Pfizer agrees to buy Esperion for US$1.3b

B>NEW YORK:/BPfizer Inc has agreed to buy Esperion Therapeutics Inc for about US$1.3bil, adding a promising experimental drug to its top-selling line of cholesterol products.

Business 25 Apr 2013 | 9:06 AM Premium

Another factor causing heart attacks?

NEW YORK: Thousands of heart attack victims every year have none of the notorious risk factors before their crisis - not high cholesterol, not unhealthy triglycerides.

Business 12 Feb 2013 | 12:00 AM Premium

Sanofi boosting stake in Regeneron

French drugmaker Sanofi SA is buying more shares in U.S. biotech company Regeneron Pharmaceuticals Inc, its partner in the development of potential blockbuster treatments for cholesterol and rheumatoid arthritis.

Business 07 Nov 2011 | 12:00 AM Premium

Lipitor prepares for fadeout after US$130bil sales

NEW YORK (Reuters) - It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of Pfizer's Lipitor, the cholesterol fighter that wrote its own chapter in pharmaceutical history.